A Clinical trial to study the effects of two drugs Telmisartan and Cilnidipine in patients with high blood pressure and heart disease

Efficacy, Safety and Cost effectiveness of Telmisartan and Cilnidipine in Hypertensive Patients with coronary artery disease in a tertiary care hospital.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/04/013453

Enrollment

126

Registered

2018-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients known case of Hypertensives with Coronary artery disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female patients 18-80 years of age. 2.Known hypertensive patients with coronary artery disease 3.Range of blood pressure in >140/90mmHg 4.Hypertensive patients with co morbidity conditions like Diabetes mellitus, Dyslipidemia

Exclusion criteria

Exclusion criteria: 1.Age below 18 years and above 80 years 2.Pregnant and lactating women. 3.Patients with hepatic impairment. 4.Patients with acute illness or blood pressure >180mmHg systolic or >120mmHg diastolic 5.Known hypersensitivity to telmisartan/cilnidipine.

Design outcomes

Primary

Measure	Time frame
Primary objective is to evaluate the SBP and DBP as compared to baseline of telmisartan and CilnidipineTimepoint: The blood pressure readings will be noted on Day 0, 4 weeks, 12 weeks and the end of 6 months	—

Secondary

Measure	Time frame
To compare the parameters between two groups in hypertensive patients. Samples are collected from patients and tested for Blood urea and Serum Creatinine, Sodium, Potassium, Chloride and Bicarbonate. Timepoint: The samples are collected on Day 0 and the end of 6 months.	—

Countries

India

Contacts

Public ContactDr Satyajit Mohapatra

SRM Medical College Hospital RC

satyajitmp@gmail.com9791161626

Outcome results